Venture Kick alumnus raises a CHF 3.25 million seed investment
15.02.2018
Besides the new capital injection, the ETH Zurich Spin-off pregnolia has announced two new board members
 pregnolia team
|
 |
pregnolia, Venture Kick winner of stage three in 2016, has announced the closing of a CHF 3.25 million seed round with investiere.ch, Zürcher Kantonalbank and the investment department of CADFEM. Moreover, two experienced investors and entrepreneurs will join the board of directors. Venture Kick has played an important role in the development phase enabling the realization of the first functional prototype and supporting the company with mentoring sessions.
About pregnolia
pregnolia is a women’s health medtech company, developing a diagnostic device to accurately predict the risk of premature birth during routine pregnancy consultation. Early diagnosis enables preventive intervention to prolong gestation and improve neonatal health outcome. pregnolia’s proprietary technology addresses both the health and economic challenges of preterm birth.
About pregnolia
pregnolia is a women’s health medtech company, developing a diagnostic device to accurately predict the risk of premature birth during routine pregnancy consultation. Early diagnosis enables preventive intervention to prolong gestation and improve neonatal health outcome. pregnolia’s proprietary technology addresses both the health and economic challenges of preterm birth.